Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News

Adding Radiotherapy to NAC Shows No Survival Benefit in PDAC

For patients with resectable pancreatic cancer, adding radiotherapy to neoadjuvant chemotherapy may improve pathological response, but that doesn’t translate into better outcomes.

Real-World Data Favor Upadacitinib in Bio-Exposed UC

A Portuguese real-world study finds that upadacitinib outperforms tofacitinib and ustekinumab — top-tier options after UC treatment failure — with higher remission rates at 16 and 52 weeks.

FDA Okays RAS Inhibitor Daraxonrasib for Pancreatic Cancer

Daraxonrasib is being hailed as a potential game changer for metastatic pancreatic cancer, roughly doubling survival vs chemotherapy in previously treated patients.

FDA Approves Zanidatamab Regimen for HER2-Positive GEA

Zanidatamab with tislelizumab and chemotherapy leads to overall survival of 26.4 months.

Fibermaxxing? Your Microbes (and Your Health) Say Thanks.

Scientists are making progress understanding how a fiber-rich diet can help with chronic disease.

How Strong Is Antioxidants’ Link to Cervical Cancer Risk?

While the rationale behind a beneficial effect of antioxidants on risk has merit, the study’s limitations prevent actionable conclusions.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Latest News

For patients with resectable pancreatic cancer, adding radiotherapy to neoadjuvant chemotherapy may improve pathological response, but that doesn’t translate into better outcomes.

A Portuguese real-world study finds that upadacitinib outperforms tofacitinib and ustekinumab — top-tier options after UC treatment failure — with higher remission rates at 16 and 52 weeks.

Daraxonrasib is being hailed as a potential game changer for metastatic pancreatic cancer, roughly doubling survival vs chemotherapy in previously treated patients.

Zanidatamab with tislelizumab and chemotherapy leads to overall survival of 26.4 months.

Scientists are making progress understanding how a fiber-rich diet can help with chronic disease.

While the rationale behind a beneficial effect of antioxidants on risk has merit, the study’s limitations prevent actionable conclusions.

News All Time

Iceberg Blamed in Diarrhea Outbreak; Masking Urged in Cities; DEA's Ketamine Probes

Health news and commentary gathered by MedPage Today staff

What's the Best Way to Test for Cyclospora Infection?

Microscopy and DNA tests are both viable, but sensitivity, cost, and availability vary

930 Dead in Outbreak; FDA Backtracks on Iceberg Lettuce; Chronic Cough Drug Fizzles

Health news and commentary gathered by MedPage Today staff

Novel Drug Shows Promise in Crohn's, Ulcerative Colitis

Duvakitug may be suitable for patients previously treated with advanced therapy

Singing for Chronic Belching; Excess Cancers in Crohn's; Dual Agonist for Liver Fat

News and commentary from the world of gastroenterology and hepatology

Lettuce Supplier Still the Focus in Cyclospora Outbreak, Despite Faulty Test Result

FDA says its investigation and outbreak data continue to point to Taylor Farms' iceberg lettuce

Inside the Intestinal Crypt: Untold Stories of Cyclospora

There's still much to learn about the parasite's past, present, and future

FDA Approves New Blood Test for Colon Cancer Screening

SimpleScreen CRC is indicated for adults 45 and up at average risk

Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead

Food safety leaders across the U.S. are raising alarms over federal cuts

Intensified Pre-Op Chemoradiotherapy Fails in Locally Advanced Rectal Cancer

DFS at 3 years nearly identical with the addition of irinotecan, but with more toxicity

Diabetes and Pancreas Cancer; Crohn's Tied to Joint Infections; Hypnotherapy for IBS

News and commentary from the world of gastroenterology and hepatology

Michigan Reports First Two U.S. Deaths Related to Diarrhea-Causing Parasite

The CDC says cyclosporiasis is rarely deadly

FIT-Based Screening Linked to Drop in Colorectal Cancer Mortality

Inflection point occurred around 2012, 3 years after screening program was implemented

Study Examines Link Between IBD and Psychiatric Disorders

Does psychiatric morbidity precede IBD onset or arise after diagnosis?

Pancreatic Cancer Vaccine Shows Interception Promise in High-Risk Patients

Durable immune response seen in patients with cancer precursor lesions

Best Gastro Hospitals; GI Bleeding in Jehovah's Witnesses; Steroids for DILI

News and commentary from the world of gastroenterology and hepatology

Recommended News For You

When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

Study suggests exercise could reduce breast cancer recurrence

When a Groundbreaking Cancer Therapy Causes Cancer.

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

mRNA-based COVID vaccines generate improved responses to immunotherapy

Routine breast cancer screening can bring better outcomes for patients

Recommended Articles For You

Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment 

The Growing Crisis of Aplastic Anemia: A Call for Action 

Tumor Bed Regeneration and Tissue Reconstruction: Scientific Review and Clinical Insights 

Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High weight and obesity are associated with poor outcomes in leukemia treatment.

2.

Severe obesity associated with reduced prevalence of recommended cancer screenings

3.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

4.

The combination of nitedanib and prednisone reduces exacerbations of pulmonary diseases in radiative pneumonitis

5.

Toxic fungus from King Tutankhamun's tomb yields cancer-fighting compounds—new study

1.

Understanding Melanoma: From Diagnosis to Healing and Excision in Denver

2.

Cancer in 2024: Global Trends, Challenges, and Innovations for Healthcare Professionals

3.

Intravenous Calcium for Reducing Blood Loss During Cesarean Delivery: A Review of Current Evidence

4.

Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research

5.

Integrated Frameworks in Hematology in Clinical Decision-Making

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV

4.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot